All Registry communications to: Automic Group GPO Box 5193 Sydney NSW 2001 Telephone (free call within Australia): 1300 288 664 ASX Code: CYP 23 October 2026 Upcoming Annual General Meeting of Shareholders Dear Shareholder Cynata Therapeutics Limited ACN 104 037 372 (ASX: CYP or “the Company”),...
Letter to Shareholders, Notice of AGM & Proxy Form
Filed with ASX · · 43 pages · English
Summary by 6ix AI
Cynata Therapeutics Limited has issued a letter to shareholders regarding the upcoming Annual General Meeting scheduled for late November. Shareholders are encouraged to review the accompanying explanatory memorandum and can submit proxy votes online or via other methods.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- Paul Wotton to Resign as Director from AGM
- Unmarketable Parcel Sale Facility
- Notification of buy-back - CYP
- Letter to Ineligible Shareholders-Entitlement Offer
- Letter to Eligible Shareholders-Entitlement Offer
Later from Cynata Therapeutics
- September 2026 Quarterly Activity Report & Appendix 4C
- Results of Fully Underwritten Entitlement Offer
- Consultancy Agreement
- Application for quotation of securities - CYP
- Cleansing Notice
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics